Back
Canopy Growth Vs. Keros Therapeutics Industry Stock Comparison
Sell
35
CGC
Canopy Growth
Last Price:
4.58
Seasonality Move:
21.86%
Buy
62
KROS
Keros Therapeutics
Last Price:
56.44
Seasonality Move:
54.08%
Sell
35
Canopy Growth (CGC)
is a Sell
Is Canopy Growth a Buy, Sell or Hold?
- The current Canopy Growth [CGC] share price is $4.52. The Score for CGC is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- CGC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $56.92. The Score for KROS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KROS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CGC Stock Price Chart
What is Canopy Growth's stock price today?
-
The Canopy Growth share price today is $4.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CGC is experiencing buying pressure, which is a positive indicator for future bullish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $56.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
CGC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.39 | Sell |
Relative Strength Index (14 RSI): | 33.38 | Sell |
Chaikin Money Flow: | 1881085 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.48 - 5.5) | Sell |
Bollinger Bands (100): | (5.36 - 8.52) | Sell |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.17 | Buy |
Relative Strength Index (14 RSI): | 64.2 | Buy |
Chaikin Money Flow: | -162874 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.46 - 56.8) | Buy |
Bollinger Bands (100): | (45.02 - 53.82) | Buy |
CGC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.64 | Sell |
20-day SMA: | 4.77 | Sell |
50-day SMA: | 5.98 | Sell |
200-day SMA: | 6.3 | Sell |
8-day EMA: | 4.61 | Sell |
20-day EMA: | 4.92 | Sell |
50-day EMA: | 5.67 | Sell |
200-day EMA: | 7.19 | Sell |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.92 | Buy |
20-day SMA: | 53.86 | Buy |
50-day SMA: | 50.03 | Buy |
200-day SMA: | 52.7 | Buy |
8-day EMA: | 55.87 | Buy |
20-day EMA: | 53.93 | Buy |
50-day EMA: | 51.33 | Buy |
200-day EMA: | 49.85 | Buy |
Canopy Growth Earnings Growth & CGC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.08 per share, an increase this year of $6.78 per share, and an increase next year of $0.51 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.30 per share, and a decrease next year of $0.44 per share.
Canopy Growth Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |